Project Number 5R44NS124454-02 Agency/Funding Organization NINDS Funding Year 2022 View Full Project Details for Development of a PIKFYVE antisense oligonucleotide treatment for FTD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) i. Proteostasis/Proteinopathies Researcher and Organization Principal Investigator ALWORTH, SAMUEL V Principal Investigator First Name SAMUEL V Principal Investigator Last Name ALWORTH Awardee Organization ACURASTEM, INC. Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $1,480,550 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official GILCHRIST, FLOY ANNETTE
